Chief Strategy Officer, PharmaLex, a Cencora company
How Does the Shift to Early-Stage M&A Change Due Diligence?
A well-defined scientific and strategic approach is critical for buyers in this dealmaking setting.
Outsourcing’s Evolution in the Pharma Industry
Amid shifting operating dynamics in recent years, demands for external expertise have fluctuated—leaving those arrangements that mix innovation and agility likely to win out in pharma decision-making.